175 related articles for article (PubMed ID: 37351166)
1. Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment.
Yang Z; Ji P; Li Z; Zhang R; Wei M; Yang Y; Yuan L; Han Y; Yang G
Theranostics; 2023; 13(10):3467-3479. PubMed ID: 37351166
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based
Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
[TBL] [Abstract][Full Text] [Related]
3. Selective Encapsulation of Therapeutic mRNA in Engineered Extracellular Vesicles by DNA Aptamer.
Zhang S; Dong Y; Wang Y; Sun W; Wei M; Yuan L; Yang G
Nano Lett; 2021 Oct; 21(20):8563-8570. PubMed ID: 34647460
[TBL] [Abstract][Full Text] [Related]
4. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery.
Hung ME; Leonard JN
J Extracell Vesicles; 2016; 5():31027. PubMed ID: 27189348
[TBL] [Abstract][Full Text] [Related]
5. "All-in-One" Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia.
Mei R; Wan Z; Li Z; Wei M; Qin W; Yuan L; Liu L; Yang G
ACS Appl Mater Interfaces; 2022 Nov; 14(45):50626-50636. PubMed ID: 36342824
[TBL] [Abstract][Full Text] [Related]
6. AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.
Somanathan S; Jacobs F; Wang Q; Hanlon AL; Wilson JM; Rader DJ
Circ Res; 2014 Aug; 115(6):591-9. PubMed ID: 25023731
[TBL] [Abstract][Full Text] [Related]
7. Construction of Fusion Protein for Enhanced Small RNA Loading to Extracellular Vesicles.
Es-Haghi M; Neustroeva O; Chowdhury I; Laitinen P; Väänänen MA; Korvenlaita N; Malm T; Turunen MP; Turunen TA
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833188
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
9. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
10. Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE
Zhang L; Wang C; Hu W; Bu T; Sun W; Zhou T; Qiu S; Wei M; Xing H; Li Z; Yang G; Yuan L
Theranostics; 2023; 13(14):5114-5129. PubMed ID: 37771781
[TBL] [Abstract][Full Text] [Related]
11. Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels.
O'Grady T; Njock MS; Lion M; Bruyr J; Mariavelle E; Galvan B; Boeckx A; Struman I; Dequiedt F
BMC Biol; 2022 Mar; 20(1):72. PubMed ID: 35331218
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis.
He Y; Rodrigues RM; Wang X; Seo W; Ma J; Hwang S; Fu Y; Trojnár E; Mátyás C; Zhao S; Ren R; Feng D; Pacher P; Kunos G; Gao B
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33301423
[TBL] [Abstract][Full Text] [Related]
13. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters.
Lai CP; Kim EY; Badr CE; Weissleder R; Mempel TR; Tannous BA; Breakefield XO
Nat Commun; 2015 May; 6():7029. PubMed ID: 25967391
[TBL] [Abstract][Full Text] [Related]
14. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery.
Ilahibaks NF; Ardisasmita AI; Xie S; Gunnarsson A; Brealey J; Vader P; de Jong OG; de Jager S; Dekker N; Peacock B; Schiffelers RM; Sluijter JPG; Lei Z
J Control Release; 2023 Mar; 355():579-592. PubMed ID: 36746337
[TBL] [Abstract][Full Text] [Related]
15. Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site.
Kulseth MA; Berge KE; Bogsrud MP; Leren TP
J Hum Genet; 2010 Oct; 55(10):676-80. PubMed ID: 20703241
[TBL] [Abstract][Full Text] [Related]
16. The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA.
Susan-Resiga D; Girard E; Kiss RS; Essalmani R; Hamelin J; Asselin MC; Awan Z; Butkinaree C; Fleury A; Soldera A; Dory YL; Baass A; Seidah NG
J Biol Chem; 2017 Feb; 292(5):1573-1590. PubMed ID: 27998977
[TBL] [Abstract][Full Text] [Related]
17. The characterization of RNA-binding proteins and RNA metabolism-related proteins in fungal extracellular vesicles.
Dallastella M; de Oliveira WK; Rodrigues ML; Goldenberg S; Alves LR
Front Cell Infect Microbiol; 2023; 13():1247329. PubMed ID: 37780856
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes.
Ilahibaks NF; Kluiver TA; de Jong OG; de Jager SCA; Schiffelers RM; Vader P; Peng WC; Lei Z; Sluijter JPG
J Extracell Vesicles; 2024 Jan; 13(1):e12389. PubMed ID: 38191764
[TBL] [Abstract][Full Text] [Related]
19. Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor).
Ben Djoudi Ouadda A; Gauthier MS; Susan-Resiga D; Girard E; Essalmani R; Black M; Marcinkiewicz J; Forget D; Hamelin J; Evagelidis A; Ly K; Day R; Galarneau L; Corbin F; Coulombe B; Çaku A; Tagliabracci VS; Seidah NG
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1996-2013. PubMed ID: 31553664
[TBL] [Abstract][Full Text] [Related]
20. Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions.
Nawaz M; Heydarkhan-Hagvall S; Tangruksa B; González-King Garibotti H; Jing Y; Maugeri M; Kohl F; Hultin L; Reyahi A; Camponeschi A; Kull B; Christoffersson J; Grimsholm O; Jennbacken K; Sundqvist M; Wiseman J; Bidar AW; Lindfors L; Synnergren J; Valadi H
Adv Sci (Weinh); 2023 Apr; 10(12):e2206187. PubMed ID: 36806740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
